Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioSig Technologies Inc BSGM

BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is... see more

Recent & Breaking News (NDAQ:BSGM)

BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

GlobeNewswire May 21, 2021

BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System

GlobeNewswire May 4, 2021

BioSig Technologies, Inc. Invited to Present at Wall Street Conference

GlobeNewswire May 3, 2021

BioSig's PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona

GlobeNewswire April 27, 2021

BioSig Expands Commercial Team in Two Strategic Regions

GlobeNewswire April 15, 2021

BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform

GlobeNewswire April 14, 2021

BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study

GlobeNewswire April 13, 2021

BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)

GlobeNewswire April 9, 2021

EP Lab Digest Features Physician Experience with BioSig's Cardiac Signal Acquisition Technology

GlobeNewswire April 8, 2021

BioSig lands Commercial Sales to Leading Hospital System

GlobeNewswire April 6, 2021

BioSig Technologies, Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference

GlobeNewswire April 5, 2021

BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing Technology

GlobeNewswire March 30, 2021

BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021

GlobeNewswire March 29, 2021

BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference

GlobeNewswire March 19, 2021

BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference

GlobeNewswire March 10, 2021

BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH Conference

GlobeNewswire March 9, 2021

BioSig Awarded U.S. Patent Claims for its NeuroClear(TM) Subsidiary

GlobeNewswire March 4, 2021

BioSig Appoints Brenda Castrodad to Lead Human Resources

GlobeNewswire February 16, 2021

Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP(TM) Systems

GlobeNewswire February 10, 2021

Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing

Canada NewsWire February 8, 2021